| 0.8661 Data as of 1:30pm ET |  -0.0239 / -2.69%Today’s Change | 0.61 Today|||52-Week Range 1.85 | -5.86% Year-to-Date |
| Previous close | 0.89 |
| Today’s open | 0.86 |
| Day’s range | 0.85 - 0.88 |
| Volume | 69,318 |
| Average volume (3 months) | 685,087 |
| Market cap | $90.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -158.33% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +58.48% |
| P/E ratio | NM |
| Price/Sales | 1.53 |
| Price/Book | 2.50 |
| Today’s change | Today’s % change | |
|---|---|---|
| ANTHAnthera Pharmaceutic... | +0.00 | +0.21% |
| CPIXCumberland Pharmaceu... | +0.12 | +2.53% |
| DSCODiscovery Laboratori... | 0.00 | 0.00% |
| PRANPrana Biotechnology ... | -0.02 | -1.09% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $53.1M |
| Annual profit (last year) | $16.2M |
| Net profit margin | 30.53% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Scientific Officer Felix Theeuwes, DSc |
President, Chief Executive Officer & Director James E. Brown, MD |
Corporate headquarters Cupertino, California |
.
